This study compound was to start with noted by Hoffman-La Roche in 2009. It’s among several benzodiazepines within the imidazobenzodiazepine subgroup considered to provide nootropic benefits. It’s unclear why this drug wasn’t investigated further more, but there are reports this compound continues to be detected on designer and street-degree drug https://jamesk799ywt0.eveowiki.com/user